Define choledocholithiasis

Reading File

Now I'll search the medical library for choledocholithiasis content in parallel:

Finding Sources

Good results. Now let me read the most comprehensive sections from Sleisenger & Fordtran (the gold-standard GI textbook) and Sabiston Surgery:

Reading File

I now have rich content from multiple authoritative textbooks. Let me also fetch the intraoperative cholangiogram image and get the ASGE risk stratification table, then compile the answer:

Loading Image

Reading File

I now have comprehensive content to deliver a thorough answer. Here is the full definition and overview:

Choledocholithiasis

Choledocholithiasis is the presence of stones within the common bile duct (CBD). It occurs in approximately 5-20% of patients with symptomatic gallstones (cholelithiasis).

Classification

There are two main types, based on how the stones arise:

Type	Description	Stone Type	Population
Primary	De novo stone formation within the CBD itself	Brown pigment stones (precipitated bile pigments + cholesterol)	More common in Asian populations; associated with bacterial infection
Secondary	Stones formed in the gallbladder that migrate into the CBD	Cholesterol or black pigment stones	More common in the United States

A subset called retained stones refers to secondary stones identified in the CBD within 2 years after cholecystectomy; these occur in 1-2% of post-cholecystectomy patients.

Sabiston Textbook of Surgery, p. 1832

Clinical Presentation

Choledocholithiasis may be asymptomatic (incidental finding) or may present with a spectrum of manifestations:

Biliary colic - right upper quadrant (RUQ) or epigastric pain
Obstructive jaundice - scleral icterus, dark urine, pale/acholic stools; onset is typically painful (distinguishing it from malignant obstruction, which is painless)
Ascending cholangitis (Charcot's triad: fever, jaundice, RUQ pain) - due to ascending bacterial infection from the duodenum; bacteremia is present in ~74% of cases
Gallstone pancreatitis - if the stone obstructs the pancreatic duct at the ampulla of Vater

Complications are frequently the presenting manifestation.

Symptom to Diagnosis: An Evidence Based Guide, p. 50

Diagnosis

Laboratory Findings

No lab test is pathognomonic. Key findings include:

Elevated total bilirubin - low sensitivity, high specificity for choledocholithiasis; >4 mg/dL is a very strong predictor
Elevated AST, ALT, ALP - early in the disease, transaminases rise first; later, an obstructive pattern (elevated ALP, bilirubin) dominates
Leukocytosis - raises concern for cholangitis
Lipase >3x upper limit of normal - diagnostic for concomitant pancreatitis
When elevated bilirubin is combined with an abnormal ultrasound, pre-test probability for choledocholithiasis approaches 90%; a patient with normal LFTs and normal ultrasound has <5% probability

Imaging

Modality	Notes
Transabdominal ultrasound	Sensitivity ~80%, specificity ~90% for CBD stones; CBD dilation >5-6 mm is suggestive; only ~25% of cases show a dilated CBD
CT scan	Only ~75% sensitive - not the test of choice
MRCP	Highly accurate, non-invasive; preferred for intermediate-risk patients
EUS (Endoscopic Ultrasound)	Highly sensitive and specific; preferred for low-to-intermediate risk patients to avoid unnecessary ERCP
ERCP	Gold standard - both diagnostic and therapeutic; proceed directly in high-risk patients

Sabiston Textbook of Surgery, p. 1832

ASGE Risk Stratification (Predictors of Choledocholithiasis)

Predictor Strength	Criteria
Very strong	CBD stone on transabdominal US; ascending cholangitis; bilirubin >4 mg/dL
Strong	Dilated CBD (>6 mm) on US; bilirubin 1.8-4 mg/dL
Moderate	Abnormal liver biochemical tests (other than bilirubin); age >55; clinical gallstone pancreatitis

Any very strong predictor = high likelihood
Both strong predictors present = high likelihood
No predictors = low likelihood
All other patients = intermediate likelihood
Mulholland and Greenfield's Surgery, p. 3073-3074

Intraoperative Cholangiogram

Below is an intraoperative cholangiogram demonstrating choledocholithiasis - note the filling defect (stone, indicated by arrow) in the CBD with no filling of the duodenum:

Intraoperative cholangiogram showing choledocholithiasis in an asymptomatic patient (arrow). - Sabiston Textbook of Surgery, p. 1832

Management

Management depends on the clinical context (jaundice, cholangitis, pancreatitis, or incidental finding), gallbladder status, and available expertise. The main options are:

1. Endoscopic Approach (First-line in most cases)

ERCP with endoscopic sphincterotomy and stone extraction - the primary therapy; success rate ~84-89% for complete duct clearance in a single session
Recommended in high-risk patients and for acutely ill patients with cholangitis requiring biliary decompression
Recommended for stones identified before cholecystectomy: clear duct endoscopically, then proceed with laparoscopic cholecystectomy

2. Surgical Approach

Laparoscopic bile duct exploration (transcystic or transcholedochal approach) - stone clearance rates average 95%, operative mortality ~0.5%
Preferred when choledocholithiasis is discovered intraoperatively and surgeon expertise allows it
Open bile duct exploration - reserved for large impacted stones, multiple failed endoscopic attempts, or anatomy precluding endoscopy (e.g., prior Roux-en-Y gastric bypass)

3. Percutaneous Approach

Used when endoscopic and surgical options are not feasible

Summary of Timing Decisions

Scenario	Preferred Approach
High risk + cholangitis	ERCP first, then cholecystectomy
Severe gallstone pancreatitis with persistent CBD stones	ERCP first
Stone found preoperatively, no cholangitis	ERCP + laparoscopic cholecystectomy OR single-stage laparoscopic cholecystectomy + CBD exploration
Stone found during laparoscopic cholecystectomy	Laparoscopic CBD exploration OR complete cholecystectomy + postoperative ERCP
Large/impacted stones or failed ERCP	Open CBD exploration

Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 1267
Mulholland and Greenfield's Surgery, p. 3074-3075

In summary, choledocholithiasis is the presence of gallstones in the common bile duct, most commonly arising from migration of gallbladder stones (secondary type). It can range from asymptomatic to life-threatening cholangitis. Risk stratification using clinical, laboratory, and imaging findings guides the choice between ERCP, laparoscopic CBD exploration, or open surgery, and the sequencing of these procedures relative to cholecystectomy.

Give me the answer on biliary struc- strictures. Describe the cause and risk factor of the biliary strictures. Explain the pathophysiology of the same and their effect on bile flow and liver function. Describe the clinical manifestation of biliary strictures.

Finding Sources

Now reading all the key sections in parallel:

Reading File

Excellent content found. Now let me read further into Maingot's for pathogenesis details and search for pathophysiology and clinical manifestations sections:

Reading File

Finding Sources

Now reading the pathophysiology sections from Robbins Pathology, Schwartz's Surgery, and Yamada's in parallel:

Reading File

Good rich data so far. Let me now fetch the cholangiogram image showing biliary stricture from Schwartz's, and also get the PSC section from Bailey & Love and the cholestasis section from Schwartz's:

Loading Image

Reading File

Excellent. Also fetching the PSC ERCP image and reading Maingot's clinical presentation section:

Loading Image

Reading File

I now have the Bismuth and Strasberg classification tables plus rich content on clinical presentation. Let me fetch the Bismuth classification diagram and read the clinical presentation section from Maingot's:

Loading Image

Reading File

I now have comprehensive content from multiple authoritative textbooks. Let me compile the full answer.---

Biliary Strictures

A biliary stricture is an abnormal narrowing of the bile duct lumen - either the intrahepatic or extrahepatic biliary tree - that impairs or obstructs the flow of bile from the liver to the duodenum. Strictures can be benign or malignant in origin.

1. Causes and Risk Factors

Biliary strictures are broadly categorized as benign or malignant.

A. Benign Biliary Strictures

i. Iatrogenic / Postoperative (Most Common)

Operative injury is the leading cause of benign biliary stricture, accounting for the vast majority of cases.

Cholecystectomy - responsible for >90% of postoperative biliary strictures in the US; laparoscopic cholecystectomy carries a 2-3x higher rate of major bile duct injury (0.4-1.3%) compared to the open technique (0.2-0.3%)
Choledochotomy (bile duct exploration)
Gastrectomy
Hepatic resection
Liver transplantation - hepatic artery thrombosis post-transplant is a recognised cause of ischemic biliary stricture

The classic laparoscopic injury involves misidentification of the common bile duct (CBD) as the cystic duct, leading to clipping and division of the CBD.

Risk factors for intraoperative bile duct injury:

Category	Specific Factors
Pathologic	Acute cholecystitis, cholangitis, gallstone pancreatitis, severe portal hepatis inflammation
Anatomic	Short cystic duct, low cystic duct insertion, long common wall between cystic duct and CBD, aberrant right sectoral duct
Technical	Limited laparoscopic field of view, excessive clip placement, injudicious electrocautery, bleeding obscuring anatomy, obesity

Maingot's Abdominal Operations, p. 1057-1058

ii. Inflammatory / Chronic

Choledocholithiasis (CBD stones) - recurrent stone impaction and cholangitis produce fibrosis and stricture formation
Chronic pancreatitis - fibrosis of the pancreatic head compresses the intrapancreatic portion of the CBD
Cholangitis (acute/recurrent) - ascending bacterial infection causes ductal wall inflammation and subsequent scarring
Primary Sclerosing Cholangitis (PSC) - autoimmune disease, more common in males, strongly associated with inflammatory bowel disease (especially ulcerative colitis); causes multifocal fibro-inflammatory stricturing of intra- and extrahepatic bile ducts
IgG4-related cholangitis - immune-mediated segmental or diffuse narrowing; responds to corticosteroids
Parasitic infections - liver flukes (Clonorchis sinensis, Opisthorchis viverrini), Ascariasis; mechanical obstruction plus chronic ductal inflammation leads to fibrosis
AIDS cholangiopathy - opportunistic infections (CMV, Cryptosporidium) in immunocompromised patients

iii. Congenital

Biliary atresia - fibro-inflammatory obliteration of the bile ducts in neonates

iv. Radiation-induced

Radiotherapy to the upper abdomen can cause late-onset ductal fibrosis and stricture

v. Traumatic

Blunt abdominal trauma; penetrating injury to extrahepatic bile ducts

vi. Mirizzi's Syndrome

External compression of the common hepatic duct by a large stone impacted in the cystic duct or gallbladder neck, causing a functional biliary stricture

B. Malignant Biliary Strictures

Cholangiocarcinoma - most common primary malignancy causing biliary stricture; patients with PSC have significantly elevated risk
Pancreatic carcinoma - compresses the intrapancreatic CBD; typically presents as painless progressive jaundice
Gallbladder carcinoma - causes obstruction by direct invasion or secondary stricture
Ampullary carcinoma - obstruction at the ampulla of Vater
Metastatic lymphadenopathy - periportal nodes compressing the hilum
Frameworks for Internal Medicine, p. 9376-9381; Bailey and Love's Short Practice of Surgery, p. 1275

2. Pathophysiology - Effect on Bile Flow and Liver Function

A. Mechanical Obstruction of Bile Flow

A biliary stricture creates a fixed mechanical barrier to the antegrade flow of bile. The sequence of events is:

Increased luminal pressure proximal to the stricture - bile continues to be secreted by hepatocytes but cannot drain freely
Proximal ductal dilation - the bile ducts upstream of the stricture dilate as back-pressure builds
Biliary stasis - stagnant bile predisposes to stone formation, infection, and colonization by enteric bacteria (ascending cholangitis)
Cholestasis - impaired bile flow leads to accumulation of bile constituents (bilirubin, bile acids, cholesterol) in the hepatic parenchyma and bloodstream

"Cholestasis occurs with impaired bile flow, leading to accumulation of bile pigment in the hepatic parenchyma. Large bile duct obstruction is most commonly associated with gallstones and carcinomas; ascending cholangitis may develop. Chronic obstruction can lead to secondary sclerosing cholangitis and cirrhosis."

Robbins, Cotran & Kumar Pathologic Basis of Disease

B. Effects on Liver Function

Prolonged biliary obstruction has a cascade of hepatic consequences:

Effect	Mechanism
Conjugated (direct) hyperbilirubinemia	Conjugated bilirubin accumulates in hepatocytes and is secreted into the circulation; being water-soluble, it is filtered in the urine (bilirubinuria)
Elevated Alkaline Phosphatase (ALP) and GGT	Biliary obstruction stimulates increased synthesis and release of ALP from bile duct epithelium; GGT is an early, sensitive marker
Mild transaminase elevation	Secondary hepatocellular injury from bile acid toxicity
Bile acid retention	Bile acids accumulate in the blood, depositing in skin and causing pruritus
Fat malabsorption	Deficient bile delivery to the duodenum impairs emulsification and absorption of dietary fats and fat-soluble vitamins (A, D, E, K)
Coagulopathy	Vitamin K malabsorption leads to deficient production of clotting factors II, VII, IX, X; PT/INR prolonged
Secondary biliary fibrosis	Persistent cholestasis activates hepatic stellate cells via bile acid-mediated and inflammatory pathways, driving periportal and periductal fibrosis
Secondary biliary cirrhosis	Untreated, long-standing obstruction leads to progressive fibrosis, loss of hepatic architecture, and cirrhosis within approximately 5 years
Portal hypertension	Cirrhosis-related increased resistance in the portal circulation leads to portal hypertension with its sequelae (varices, ascites, splenomegaly)
Liver failure	End-stage consequence of unrelieved obstruction

"Inflammation of the biliary tree results in fibrosis and stricture formation. Due to stricture formation, biliary stasis occurs, which predisposes patients to infection and hepatic abscess formation. Long-term complications include cirrhosis and liver failure."

Yamada's Textbook of Gastroenterology

"Bile duct strictures that go unrecognized or are improperly managed can lead to severe complications such as recurrent cholangitis, secondary biliary cirrhosis, and portal hypertension."

Schwartz's Principles of Surgery, p. 1446

C. Inflammatory Pathways (PSC)

In PSC and inflammatory strictures, the mechanism is distinct: periductal inflammation and fibrosis develop concentrically around the bile ducts ("onion-skin" pattern on histology), progressively obliterating the ductal lumen. This leads to the same downstream consequences of cholestasis but also to multisegmental stricturing and beading of the biliary tree.

3. Classification of Biliary Strictures (Bismuth Classification)

Biliary strictures are classified by anatomical level, which guides surgical planning:

Bismuth Classification of bile duct strictures - Types I through V based on distance from the hepatic confluence

Bismuth classification of bile duct strictures based on level in relation to the confluence of hepatic ducts. Types III-V are considered complex. - Maingot's Abdominal Operations

Bismuth Type	Location
I	Stricture >2 cm below the hepatic confluence
II	Stricture <2 cm below the hepatic confluence
III	Stricture at the hepatic confluence; hepatic ducts remain in continuity
IV	Stricture involving right and left hepatic ducts; ducts not in continuity
V	Stricture involving a right sectoral duct

The Strasberg classification expands this to include types A-E, with E subtypes corresponding to Bismuth types I-V.

4. Clinical Manifestations

A. Early / Acute Presentation (Bile Duct Injury / Leak)

When a bile duct injury is unrecognized at surgery and results in a bile leak:

Abdominal pain and distension - typically within the first week post-operatively
Nausea and vomiting
Fever and signs of sepsis - tachycardia, hypotension in severe cases
Bilious drainage from incision sites or operative drains
Biloma - loculated bile collection, presenting as a low-grade fever and localized pain
Chemical peritonitis or frank biliary peritonitis if bile drains freely into the peritoneum
Biliary ascites in severe leaks

B. Subacute and Chronic Presentation (Established Stricture)

Bile duct strictures may present months to years after the inciting event:

Symptom/Sign	Description
Jaundice	Yellow discoloration of skin, sclera, and mucous membranes; detectable when serum bilirubin >2.5-3 mg/dL; may be the sole presenting feature
Pruritus	Intense itching due to bile acid deposition in skin; often preceding or accompanying jaundice; patients may have multiple excoriations on examination
Right upper quadrant (RUQ) pain	Dull aching or biliary colic-type pain from ductal distension
Dark urine (bilirubinuria)	Water-soluble conjugated bilirubin filtered by kidneys
Pale/acholic stools	Absence of bile pigment (urobilinogen) from stool
Cholangitis (Charcot's Triad)	Fever + jaundice + RUQ pain; the most common presentation of benign biliary strictures; may progress to sepsis with hypotension and altered consciousness (Reynolds' Pentad)
Steatorrhoea	Fatty, malodorous stools from fat malabsorption due to deficient intraluminal bile
Weight loss	Malabsorption and anorexia
Hepatomegaly	Palpable enlarged liver due to intrahepatic bile duct dilation or underlying hepatocellular damage
Splenomegaly	Suggests portal hypertension from secondary biliary cirrhosis
Unexplained fever / malaise	Particularly in isolated right sectoral duct injuries; episodes of mild cholangitis

"Bile duct strictures most commonly result in recurrent episodes of cholangitis but may present with isolated jaundice without infection. Liver function tests usually show evidence of cholestasis with elevations of bilirubin and alkaline phosphatase."

Schwartz's Principles of Surgery, p. 1446

"Patients with a slowly evolving stricture may have nonspecific abdominal complaints, jaundice, pruritus, cholangitis, or derangements in liver function tests... patients can present with painless jaundice, which can be confused with a malignant stricture."

Maingot's Abdominal Operations, p. 1061

ERCP Imaging of Biliary Strictures

Below: ERCP showing a stricture of the common hepatic duct (arrow) in a patient following laparoscopic cholecystectomy. Clips from the operation are visible projected over the CBD.

ERCP showing stricture of the common hepatic duct (arrow) after laparoscopic cholecystectomy

ERCP showing stricture of the common hepatic duct (arrow) - Schwartz's Principles of Surgery

PSC: Stricturing and Beading Pattern on ERCP

ERCP showing sclerosing cholangitis with characteristic stricturing and beading of bile ducts in a patient with ulcerative colitis

ERCP demonstrating the characteristic stricturing and beading pattern of PSC in a patient with ulcerative colitis - Bailey & Love's Short Practice of Surgery, p. 1276

5. Laboratory Findings Summary

Test	Expected Finding	Significance
Serum bilirubin (conjugated)	Elevated	Cholestasis from obstruction
Alkaline phosphatase (ALP)	Markedly elevated	Biliary epithelial synthesis/release
GGT	Elevated	Sensitive early marker of hepatobiliary obstruction
AST / ALT	Mildly elevated	Secondary hepatocellular injury
Prothrombin time (PT/INR)	Prolonged	Vitamin K malabsorption
WBC	Elevated (leukocytosis)	Suggests superimposed cholangitis
IgG4 levels	May be elevated	Suggests IgG4-related cholangiopathy
Lipase	Elevated >3x ULN	Concomitant pancreatitis

In summary, biliary strictures arise most commonly from surgical injury (especially laparoscopic cholecystectomy), but also from inflammatory, autoimmune, parasitic, malignant, and congenital processes. The core pathophysiology is mechanical obstruction of bile flow, producing upstream ductal hypertension and biliary stasis, which triggers cholestasis, hepatocellular injury, fibrosis, and eventually secondary biliary cirrhosis if untreated. Clinically, they manifest as recurrent cholangitis, obstructive jaundice with its systemic consequences (pruritus, steatorrhoea, coagulopathy), and ultimately liver failure - with the clinical picture varying depending on whether the presentation is acute (bile leak) or chronic (established stricture).

Pay

Pathophysiology of surgical jaundice in flow chart

Finding Sources

Reading File

Finding Sources

I have sufficient foundational content from the previous session (Schwartz's, Robbins, Yamada's, Bailey & Love) combined with what I've now retrieved. I have enough to build a comprehensive, accurate flowchart-style answer on the pathophysiology of surgical jaundice.

Reading File

I now have all the textbook content needed to construct a thorough flowchart-style answer. Here it is:

Pathophysiology of Surgical (Obstructive) Jaundice - Flowchart

Surgical jaundice = posthepatic (obstructive) jaundice caused by mechanical blockade of bile outflow from an extrahepatic cause. The liver conjugates bilirubin normally, but the conjugated product cannot be excreted.

Master Flowchart

CAUSE OF OBSTRUCTION
        │
        ▼
┌─────────────────────────────────────────────────────────────────┐
│  SURGICAL / MECHANICAL CAUSES                                   │
│  • Choledocholithiasis (CBD stones)                             │
│  • Malignancy (pancreatic Ca, cholangiocarcinoma, ampullary Ca) │
│  • Biliary stricture (post-op, PSC, chronic pancreatitis)       │
│  • Mirizzi's syndrome                                           │
│  • Biliary atresia (neonatal)                                   │
│  • Choledochal cyst, parasitic obstruction                      │
└─────────────────────────────────────────────────────────────────┘
        │
        ▼
MECHANICAL OBSTRUCTION OF EXTRAHEPATIC BILE DUCT
        │
        ▼
┌──────────────────────────────────┐
│ INCREASED INTRADUCTAL PRESSURE   │
│ Bile secretion continues but     │
│ cannot drain distally            │
└──────────────────────────────────┘
        │
        ├──────────────────────────────────────────────────┐
        ▼                                                  ▼
PROXIMAL BILE DUCT DILATION                       BILIARY STASIS
(Upstream ducts, intrahepatic ducts,               Stagnant bile pools
 gallbladder distension if patent)                 proximal to obstruction
        │                                                  │
        ▼                                                  ▼
INTRAHEPATIC DUCTAL HYPERTENSION              BACTERIAL COLONIZATION
Bile forced back into hepatocytes             (Ascending from duodenum)
        │                                                  │
        ▼                                                  ▼
DISRUPTION OF CANALICULAR TRANSPORT   ──→  ACUTE CHOLANGITIS
(Failure of bile salt export pumps)         (Fever + Jaundice + RUQ pain)
        │                                   = Charcot's Triad
        ▼
REGURGITATION OF CONJUGATED BILIRUBIN
INTO SINUSOIDS → BLOODSTREAM

Downstream Systemic Cascade

REGURGITATION OF CONJUGATED BILIRUBIN INTO BLOOD
        │
        ├──────────────────────────────────────────────────────────────────────┐
        ▼                                                                      ▼
CONJUGATED HYPERBILIRUBINEMIA                              BILE ACIDS RETAINED IN BLOOD
(Direct bilirubin ↑↑; water-soluble)                       (Cholemia)
        │                                                          │
        ├──────────────┐                                           ├──────────────────────┐
        ▼              ▼                                           ▼                      ▼
JAUNDICE           BILIRUBINURIA                        PRURITUS                  BRADYCARDIA
(Skin + sclera     (Dark/tea-coloured                  (Bile acid deposition      (Bile acids sensitize
 icteric when      urine; "coca-cola                    in skin; intense           cardiac conduction
 bili > 2.5-3      urine")                              generalised itching)       system)
 mg/dL)
        │
        ▼
ABSENT BILIRUBIN IN GUT
        │
        ├──────────────────────────────────┐
        ▼                                  ▼
PALE / ACHOLIC STOOLS              FAT MALABSORPTION
(No stercobilinogen)               (No bile for micelle formation)
                                           │
                               ┌───────────┴────────────────────┐
                               ▼                                ▼
                       STEATORRHOEA                  FAT-SOLUBLE VITAMIN
                       (Fatty, bulky,                DEFICIENCY
                        foul-smelling stools)         (Vit A, D, E, K)
                                                             │
                                                             ▼
                                                    VITAMIN K DEFICIENCY
                                                    (Clotting factors
                                                     II, VII, IX, X ↓)
                                                             │
                                                             ▼
                                                     COAGULOPATHY
                                                     (Prolonged PT/INR)
                                                     Risk of bleeding

Effects on Liver Parenchyma

SUSTAINED BILIARY OBSTRUCTION
        │
        ▼
BILE ACID ACCUMULATION IN HEPATOCYTES
(Hepatotoxic at high concentrations)
        │
        ▼
HEPATOCELLULAR INJURY
(AST ↑, ALT ↑ — mild)
        │
        ▼
PERIDUCTAL & PERIPORTAL INFLAMMATION
        │
        ▼
ACTIVATION OF HEPATIC STELLATE CELLS
(Fibrogenesis: TGF-β, PDGF)
        │
        ▼
PROGRESSIVE HEPATIC FIBROSIS
        │
        ▼
SECONDARY BILIARY CIRRHOSIS
(~5 years of untreated obstruction)
        │
        ├──────────────────────────────────────────────┐
        ▼                                              ▼
PORTAL HYPERTENSION                       HEPATOCELLULAR INSUFFICIENCY
        │                                              │
   ┌────┴────────────────────┐              ┌──────────┴──────────────┐
   ▼           ▼             ▼              ▼                         ▼
OESOPHAGEAL  ASCITES    SPLENOMEGALY   SYNTHETIC                 HEPATIC
VARICES      (+ SBP risk)  (Hypersplenism)  FAILURE                  ENCEPHALOPATHY
(Bleeding)                             (↓ Albumin,
                                        ↓ Clotting factors,
                                        ↓ Gluconeogenesis)

Renal Complications

OBSTRUCTIVE JAUNDICE
        │
        ├─────────────────────────────────────────────────────────┐
        ▼                                                         ▼
BILE ACIDS IN SYSTEMIC CIRCULATION                     SEPSIS (from cholangitis)
(Direct renal tubular toxicity)                                   │
        │                                                         ▼
        ▼                                               REDUCED RENAL PERFUSION
RENAL TUBULAR DYSFUNCTION                              (Hypotension, ↓ cardiac output)
        │                                                         │
        └──────────────────────────┬──────────────────────────────┘
                                   ▼
                        ACUTE KIDNEY INJURY (AKI)
                        ("Obstructive nephropathy")
                        - Oliguria
                        - Rising creatinine
                        Risk is highest in malignant/
                        complete obstruction + cholangitis

Immune / Endotoxin Pathway

BILIARY STASIS + BACTERIAL COLONISATION
        │
        ▼
ENDOTOXIN ABSORPTION FROM GUT (Reduced bile in duodenum
        │                       → ↓ Kupffer cell function
        │                       → Increased gut permeability)
        ▼
SYSTEMIC ENDOTOXAEMIA
        │
        ├──────────────────────────────────┐
        ▼                                  ▼
SYSTEMIC INFLAMMATORY             IMPAIRED KUPFFER CELL
RESPONSE (SIRS)                   PHAGOCYTOSIS
        │                         (Kupffer cells normally
        ▼                          detoxify endotoxin)
SEPSIS / SEPTIC SHOCK
(Especially if cholangitis present)
        │
        ▼
MULTI-ORGAN DYSFUNCTION (MOD)
(Kidneys, lungs, heart, brain)

Haematological Effects

OBSTRUCTIVE JAUNDICE
        │
        ├─────────────────────────────────────────────────┐
        ▼                                                  ▼
VITAMIN K MALABSORPTION                        ENDOTOXIN-MEDIATED
        │                                       PLATELET DYSFUNCTION
        ▼                                                  │
↓ Factors II, VII, IX, X                                   ▼
        │                                        DISSEMINATED INTRAVASCULAR
        ▼                                        COAGULATION (DIC) in severe
COAGULOPATHY / BLEEDING RISK                    sepsis / MOD
(↑ PT/INR, ↑ APTT)

Summary Table: Consequences of Surgical Jaundice

System	Effect	Mechanism
Skin/Sclera	Jaundice, pruritus, excoriations	Conjugated bilirubin + bile acid deposition
Urine	Dark (bilirubinuria)	Water-soluble conjugated bilirubin filtered renally
Stool	Pale/acholic	No bilirubin/urobilinogen reaching gut
GI Tract	Steatorrhoea, malabsorption	No bile acids for fat emulsification
Nutrition	Fat-soluble vitamin deficiency (A, D, E, K)	Impaired absorption
Coagulation	Coagulopathy, bleeding	Vitamin K deficiency → ↓ Factors II, VII, IX, X
Liver	Fibrosis → secondary biliary cirrhosis	Bile acid toxicity + stellate cell activation
Portal circulation	Portal hypertension, varices, ascites, splenomegaly	Cirrhosis-related obstruction
Kidney	AKI ("obstructive nephropathy")	Bile acid nephrotoxicity + sepsis-related hypoperfusion
Cardiovascular	Bradycardia, hypotension	Bile acid sensitisation of cardiac conduction; sepsis
Immune	Endotoxaemia, SIRS, sepsis	↓ bile in gut → ↑ gut permeability + ↓ Kupffer cell function
CNS	Encephalopathy (late)	Hepatocellular failure in secondary biliary cirrhosis

Core concept: Surgical jaundice is not just a cosmetic discoloration - it is a multi-system disease. The initiating event (mechanical bile duct obstruction) triggers a cascade involving cholestasis, bile acid retention, fat malabsorption, coagulopathy, hepatocellular injury, and - if unrelieved - secondary biliary cirrhosis, renal failure, and sepsis. Early decompression (ERCP, surgery, or percutaneous drainage) is the only way to interrupt this cascade.

Schwartz's Principles of Surgery, pp. 1381-1382; Robbins & Kumar Basic Pathology, p. 619; Schwartz's Principles of Surgery, p. 1446

17839494616702858331946428672592.jpg

Can make answer of all 4 at once or else will do one by one ?

I can absolutely answer all 4 topics at once! The image shows questions 23-26 covering:

Q23 - Splenomegaly (MSLV)
Q24 - Splenic Artery Aneurysm (MSOV)
Q25 - Splenic Infarction (MSOV)
Q26 - Splenic Abscess (MSOV)

Let me search the medical library for all four topics simultaneously.

Finding Sources

Excellent hits across all 4 topics. Now reading all key sections in parallel:

Reading File

Good content flowing in. Now reading the Sabiston SAA section, Goldman-Cecil splenomegaly diagnosis, Robbins splenomegaly, and Maingot SAA in parallel:

Reading File

Excellent data from all 4 topics. Let me now fetch the key images and get the Sabiston splenic abscess and splenomegaly anatomy sections:

Loading Image

Reading File

I now have comprehensive content for all 4 questions. Let me fetch the CT splenomegaly image and compile the full answer:

Loading Image

Here are all 4 complete answers:

Q23 - Splenomegaly (MSLV)

Anatomy and Physiology of the Spleen Relevant to Splenomegaly

The spleen is the largest lymphatic organ in the body, situated in the left upper quadrant, posterior to the stomach, and protected by the 9th-11th ribs. It has three functional compartments:

Compartment	Structure	Function
White pulp	Periarterial lymphatic sheath + lymphoid follicles	Immune response to blood-borne antigens; B and T lymphocyte activation; removes microorganisms and foreign proteins
Marginal zone	Transition between white and red pulp	Interface for antigen processing
Red pulp	Splenic cords + sinusoids; >50% of splenic volume	Filtration and destruction of senescent/defective red blood cells (mechanical + immunologic phagocytosis); platelet and leukocyte sequestration

Additional functions include:

Blood volume regulation - splenic contraction and the splenorenal reflex promotes fluid/sodium retention
Phagocytosis of encapsulated bacteria - absence (post-splenectomy) predisposes to Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis infections
Platelet pooling - normally stores 30-40% of total platelet mass

The spleen must enlarge 3-fold before it becomes palpable on clinical examination. By ultrasound, splenomegaly is defined as length ≥13 cm and thickness >5 cm.

Causes of Splenomegaly

Category	Examples
Infectious	Infectious mononucleosis (EBV), malaria, leishmaniasis, tuberculosis, brucellosis, syphilis, endocarditis, HIV, CMV, histoplasmosis, typhoid
Congestive (vascular)	Liver cirrhosis with portal hypertension, portal vein thrombosis, splenic vein thrombosis, congestive cardiac failure, Budd-Chiari syndrome
Haematological malignancies	CML (massive splenomegaly), lymphoma (Hodgkin/Non-Hodgkin), acute/chronic leukaemia, myeloproliferative neoplasms, hairy cell leukaemia, myelofibrosis
Immune-mediated / autoimmune	Rheumatoid arthritis (Felty syndrome), SLE, autoimmune haemolytic anaemia, ITP, drug reactions (e.g., phenytoin)
Non-malignant haematological	Hereditary spherocytosis, thalassaemia, sickle cell disease (early), haemolytic anaemias, extramedullary haematopoiesis
Storage diseases	Gaucher disease, Niemann-Pick disease
Others	Sarcoidosis, amyloidosis, splenic cysts/pseudocysts, metastatic solid tumours

Clinical Manifestations

Incidental finding on imaging (most common presentation due to reliance on CT/US)
Left upper quadrant (LUQ) fullness or pain - particularly with rapid enlargement
Left shoulder tip pain - from diaphragmatic irritation (referred via phrenic nerve); suggests splenic infarct or capsular stretch
Early satiety - from gastric compression by the enlarged spleen
Unexplained cytopenias from hypersplenism (see below)
Catastrophic presentation - splenic rupture (spontaneous or from minor trauma)

Hypersplenism

A clinical syndrome of:

Splenic enlargement
Any combination of anaemia, leukopenia, or thrombocytopenia (platelets most commonly and severely affected - sequestration in red pulp interstices)
Compensatory bone marrow hyperplasia
Improvement after splenectomy

Diagnostic Workup

Initial Diagnostic Workup

History: Age, travel history, infectious exposures, medications, family history, systemic symptoms (fever, weight loss, night sweats)

Physical Examination:

Patient in right lateral decubitus position, knees slightly flexed
Palpation begins in the pelvis and moves upward to LUQ (to avoid missing massive splenomegaly)
Note size, tenderness, consistency, and any splenic rub
Look for jaundice, lymphadenopathy, hepatomegaly, signs of portal hypertension (ascites, caput medusae, varices)

Laboratory Investigations (CBC + Liver Function + Imaging)

Test	Finding	Significance
CBC + peripheral smear	Anaemia, thrombocytopenia, leukopenia	Hypersplenism; peripheral smear may show abnormal lymphocytes (lymphoma/leukaemia), spherocytes (hereditary spherocytosis), sickle cells, malaria parasites, Howell-Jolly bodies (asplenic), blast cells
Liver function tests	Elevated bilirubin, ALP, ALT, low albumin	Chronic liver disease with portal hypertension
LDH and uric acid	Elevated	Lymphoid/myeloid malignancies
Bone marrow biopsy	Hyperplasia, infiltration by malignant cells	Haematological malignancies, storage diseases
Flow cytometry	Abnormal cell populations	Lymphoma, leukaemia
Thick blood smear	Parasites	Malaria
Monospot test / EBV serology	Positive heterophile antibodies	Infectious mononucleosis
Splenic biopsy	Rare; sensitivity ~94%, specificity ~79%	Differentiate benign vs. malignant splenic masses

Imaging

Modality	Utility
Ultrasound (US)	First-line; measures spleen dimensions accurately; detects portal hypertension features; allows serial follow-up
CT scan	Provides comprehensive abdominal imaging; shows whether diffuse or nodular enlargement; identifies aetiology (e.g., liver cirrhosis, lymphoma); preferred for most clinical evaluations
MRI	Superior soft tissue characterisation; used for further evaluation of focal lesions or indeterminate CT findings
Splenic biopsy	Reserved when diagnosis cannot be established otherwise
FDG-PET	Not routinely useful - cannot distinguish between malignancy, infection, and other causes

CT scan showing splenomegaly (arrow) in a patient with hemophagocytic lymphohistiocytosis

CT showing splenomegaly (arrow) - Goldman-Cecil Medicine

Therapeutics

Treat the underlying cause (majority of cases)
Splenectomy is indicated only when:
- Hypersplenism causing clinically significant cytopenias
- Haematological conditions where splenectomy is therapeutic (e.g., hereditary spherocytosis, ITP refractory to medical therapy, hairy cell leukaemia, some lymphomas)
- Massive symptomatic splenomegaly (e.g., myelofibrosis)
- Splenic complications (abscess, rupture, infarction with sepsis)
Pre-splenectomy: Vaccinate against S. pneumoniae, H. influenzae type b, N. meningitidis ≥2 weeks before elective splenectomy
Goldman-Cecil Medicine, pp. 1777-1778; Robbins & Kumar Basic Pathology; Bailey & Love's Short Practice of Surgery

Q24 - Splenic Artery Aneurysm (MSOV)

Overview

Splenic artery aneurysm (SAA) is the most common visceral artery aneurysm (60% of all splanchnic artery aneurysms) and the third most common intra-abdominal arterial aneurysm after the aorta and iliac artery. Prevalence: 0.1-0.8% general population. Female predominance (4:1; some series 2-4:1).

Risk Factors

Risk Factor	Details
Female sex / multiparity	2-4x more common in women; associated with increased parity; hormonal and haemodynamic changes during pregnancy weaken arterial walls
Portal hypertension / cirrhosis	Found in 14% of patients awaiting liver transplant; increased portal flow → hyperdynamic splenic circulation
Arterial dysplasia / medial degeneration	Leading pathological mechanism (Stanley et al.)
Hypertension	Present in >50% of patients with SAA; a common comorbidity
Pancreatitis	Chronic/acute pancreatitis causes perivascular inflammation and erosion of the arterial wall, especially pseudoaneurysm formation
Atherosclerosis	More common in elderly patients; degenerative aneurysms
Autoimmune arteritis	Polyarteritis nodosa, SLE, other connective tissue disorders
Intra-abdominal sepsis	Mycotic aneurysm from contiguous infection
IV drug use	Haematogenous bacterial seeding
Prior tobacco use	Risk factor for rupture
Connective tissue disorders	Marfan syndrome, Ehlers-Danlos syndrome

Most SAAs arise at the mid- and distal main splenic artery branch points and are solitary and saccular. 90% of patients with portal HTN will have multiple SAAs.

Common Clinical Manifestations

Asymptomatic (>90%) - incidental finding on CT scan or plain abdominal X-ray (calcified "signet ring" shadow in LUQ)
Vague LUQ or epigastric discomfort - when symptomatic without rupture
Bruit on auscultation over the LUQ (rare)
GI bleeding - if aneurysm erodes into the colon, stomach, or intestine
Rupture presentations (most feared):
- Sudden severe abdominal pain
- "Double rupture" phenomenon - initial haemorrhage is contained in the lesser sac (temporary stabilisation), followed by catastrophic free intraperitoneal haemorrhage → cardiovascular collapse
- Mimics splenic rupture clinically

Rupture in Pregnancy

Occurs in 20-50% of ruptures, typically in the third trimester (69% of cases)
Maternal mortality >75%; fetal death nearly inevitable
Rupture risk is higher even with aneurysms <2 cm in pregnant women

Diagnostic Approach

Modality	Findings
Plain abdominal X-ray	Calcified "signet ring" opacity in LUQ (curvilinear calcification)
CT angiography (CTA)	Gold standard for preoperative planning; shows size, location, morphology, relationship to splenic hilum; distinguishes true aneurysm from pseudoaneurysm
MRI/MRA	Alternative to CTA; avoids radiation; useful for follow-up
Selective coeliac angiography	Confirms diagnosis; enables endovascular treatment in the same session
Doppler ultrasound	Initial screening; may detect pulsatile flow in the aneurysm sac

CT angiogram showing two splenic artery aneurysms (A) and completion angiogram after successful coil embolisation (B)

Reformatted CT angiogram showing splenic artery aneurysms (A) and post-coil embolisation angiogram (B) - Sabiston Textbook of Surgery

Diagnostic (Operative) Indications and Non-Surgical Management

Indications for Repair

Indication	Priority
Ruptured aneurysm (any size)	Emergency repair
Pseudoaneurysm (any size)	All should be repaired
Any size SAA in females of childbearing age	Elective repair due to rupture risk in pregnancy
SAA ≥3 cm with demonstrated growth or symptoms	Elective repair
Portal hypertension, especially pre-liver transplant	Elective repair (risk of haemorrhage post-transplant)
Rapid growth (>0.5 cm/year)	Repair
Non-atherosclerotic/non-degenerative SAA	Consider repair

Observation

Asymptomatic, small (<3 cm), stable SAA in elderly, high-risk patients with degenerative/calcified aneurysms - annual surveillance CT or US

Non-Surgical Management

Endovascular coil embolisation (most common current approach) - via selective splenic artery angiography; particularly for mid-splenic artery aneurysms
Endovascular stent grafting - for aneurysms at the hilum or where embolisation risks splenic infarction

Surgical Management

Open splenectomy + resection of diseased artery - traditional approach
Laparoscopic splenectomy - for distal aneurysms
Aneurysmorrhaphy or aneurysm exclusion with vascular reconstruction - for proximal aneurysms with spleen preservation
Sabiston Textbook of Surgery, pp. 1962-1984; Bailey & Love's Short Practice of Surgery; Maingot's Abdominal Operations, p. 1264-1265

Q25 - Splenic Infarction (MSOV)

Common Causes and Risk Factors

Splenic infarction results from occlusion of the splenic artery or its branches, causing ischaemic necrosis of splenic parenchyma.

Category	Specific Causes
Thromboembolism (most common)	Atrial fibrillation (emboli from the left atrium), bacterial endocarditis, left ventricular thrombus, cardiac valvular disease, atherosclerosis
Myeloproliferative disorders	CML, polycythaemia vera, myelofibrosis, essential thrombocythaemia - massively enlarged spleen with sluggish blood flow predisposes to thrombosis
Haemoglobinopathies	Sickle cell disease - repeated sickling episodes occlude splenic microvessels; results in progressive "autosplenectomy"
Haematological malignancies	Lymphoma, leukaemia
Vascular / local causes	Splenic vein thrombosis, portal hypertension, spleen-preserving distal pancreatectomy (surgical intervention disrupting splenic blood flow)
Pancreatic disease	Pancreatitis causing perivascular inflammation and thrombosis
Hypercoagulable states	Antiphospholipid syndrome, protein C/S deficiency, Factor V Leiden mutation
Trauma	Blunt trauma to LUQ

Clinical Signs and Symptoms

Asymptomatic - small infarcts may be entirely silent (incidental finding on CT)
LUQ pain - sudden onset, may be severe; sharp or dull aching character
Left shoulder tip pain - referred pain via the left phrenic nerve from diaphragmatic irritation (Kehr's sign)
Fever - especially with septic infarction
Nausea and vomiting
Splenic rub - pleuritic/peritoneal friction rub heard on auscultation over LUQ (from peritoneal reaction to the infarcted segment)
Rapid increase in spleen size due to oedema

Diagnostic Approaches

Test	Expected Finding
CBC	May show findings of underlying disease (e.g., leukocytosis in myeloproliferative disorder, sickle cells)
Blood cultures	If endocarditis or septic emboli suspected
Echocardiography	Identify cardiac source of emboli (thrombus, vegetation)
Contrast-enhanced CT (CECT)	Investigation of choice - shows characteristic wedge-shaped (triangular) hypodense perfusion defect with the base at the splenic capsule; can detect haemorrhagic infarction or complications
Doppler ultrasound	Can show absence of flow in infarcted segments; less sensitive than CT
MRI	Alternative to CT; superior characterisation of haemorrhagic changes
Angiography	Rarely needed diagnostically; may be therapeutic (embolisation)

Surgical Indications in Splenic Infarction

Indication	Management
Uncomplicated infarction	Conservative management - analgesia, anticoagulation (if embolic source identified), treat underlying cause
Septic infarction (abscess formation)	Splenectomy indicated when septic infarct causes an abscess not amenable to percutaneous drainage
Haemorrhagic infarction with haemoperitoneum	Emergency splenectomy
Persistent pain / failed conservative management	Splenectomy
Massive or total splenic infarction	Splenectomy (infected tissue, risk of rupture)
Spontaneous rupture	Emergency splenectomy

"Treatment is conservative and splenectomy should be considered only when a septic infarct causes an abscess."

Bailey & Love's Short Practice of Surgery

Bailey & Love's Short Practice of Surgery, p. 3806; Goldman-Cecil Medicine

Q26 - Splenic Abscess (MSOV)

Common Causes and Risk Factors

Splenic abscess is rare - the spleen's robust immune function (phagocytic macrophages and active immune surveillance) resists infection. Mortality: 15-20% in immunocompetent patients; up to 80% in immunocompromised patients.

Pathways of Infection

Haematogenous spread (~70%) - most common route

Bacterial endocarditis (complicates 5% of cases)
Osteomyelitis
IV drug use
Bacteraemia from any source

Contiguous spread - from adjacent structures

Pancreatic necrosis / peripancreatic abscess
Left subphrenic abscess
Colonic, renal, or other intra-abdominal infections

Splenic infarction with superinfection - especially in sickle cell disease (thrombosis → infarction → colonisation)
Trauma - haematoma formation with secondary bacterial seeding

Risk Factors

Risk Factor	Mechanism
IV drug use	Direct haematogenous seeding
HIV/AIDS and immunocompromised states	Reduced immune surveillance; fungal and mycobacterial infections (Candida, MAI, TB)
Sickle cell disease	Repeated infarctions create nidus for infection; more common in tropics
Malignancy	Polycythaemia vera, leukaemia, lymphoma - altered immunity + splenomegaly
Endocarditis	Septic emboli to splenic artery branches
Haemoglobinopathies	Structural vessel occlusion → infarction → abscess
Splenic trauma	Haematoma or splenic laceration serves as culture medium
Pancreatic necrosis	Direct contiguous spread to spleen
Puerperal sepsis, typhoid, paratyphoid	Bacteraemia with splenic seeding

Organisms

Most abscesses are polymicrobial:

Gram-positive: Staphylococcus, Streptococcus (group D), Enterococcus
Gram-negative: E. coli, Klebsiella pneumoniae, Salmonella, Proteus mirabilis
Anaerobes: Bacteroides, Fusobacterium, Peptostreptococcus, Clostridium
Fungi: Candida albicans (especially in immunocompromised)
Mycobacteria: M. tuberculosis, M. avium (in HIV)

Pathophysiology of Abscess Formation

Bacteraemia / Septic Emboli / Contiguous Spread
        ↓
Bacteria lodge in splenic parenchyma
(especially in areas of prior infarction or haematoma)
        ↓
Local tissue necrosis + neutrophil infiltration
        ↓
Abscess cavity forms with liquefactive necrosis
        ↓
Encapsulation OR rupture
        ↓
Rupture → Left subphrenic abscess / Diffuse peritonitis

Clinical Manifestations

Feature	Description
Fever	Persistent, often high-grade
LUQ pain / abdominal pain	Vague, may radiate to left shoulder
Malaise and weight loss	Systemic sepsis features
Pleuritic chest pain	From diaphragmatic involvement
Leukocytosis	Neutrophilia; elevated CRP/ESR
Splenomegaly	Variable; not typical
Peritonism	If abscess has ruptured

Note: Many patients have multiple abscesses in other organs (liver, kidneys), as splenic abscess is often part of overwhelming systemic sepsis.

Diagnostic Investigations

Test	Finding
CBC	Leukocytosis
Blood cultures	May identify causative organism; bacteraemia present in many cases
Ultrasound	First-line; shows hypoechoic or complex cystic lesion in the spleen; guides percutaneous drainage
CT scan (CECT)	Preferred modality - shows single or multiple low-density splenic lesions; characterises whether unilocular or multilocular; identifies contiguous spread; guides drainage
MRI	Used for equivocal cases or further characterisation
Culture of aspirate	Definitive microbiological diagnosis; guides antibiotic therapy

Treatment

Scenario	Management
Unilocular abscess	Percutaneous drainage (radiologically guided US or CT) + broad-spectrum IV antibiotics - high success rates; first-line approach
Multilocular or multiple abscesses	Splenectomy (laparoscopic or open) + LUQ drainage + IV antibiotics
Failed percutaneous drainage	Laparoscopic or open splenectomy
Ruptured abscess	Emergency laparotomy, splenectomy, and peritoneal lavage
Immunocompromised patients	Often require splenectomy due to fungal/mycobacterial aetiology not amenable to drainage alone

Antibiotic therapy should be continued until all drains/catheters have been removed. Coverage should be broad-spectrum (gram-positive, gram-negative, and anaerobic organisms), with antifungal added if immunocompromised.

Sabiston Textbook of Surgery, pp. 2294-2300; Maingot's Abdominal Operations, pp. 1266-1267; Bailey & Love's Short Practice of Surgery; Current Surgical Therapy 14e

Quick Reference Summary Table

Topic	Key Point
Splenomegaly	Spleen 3x enlargement before palpable; massive splenomegaly = CML / myelofibrosis; treat cause; splenectomy for hypersplenism
Splenic Artery Aneurysm	Most common visceral aneurysm; F>M; risk in pregnancy; "double rupture" into lesser sac then peritoneum; repair if ≥3 cm, symptomatic, or in woman of childbearing age; endovascular embolisation preferred
Splenic Infarction	Wedge-shaped defect on CECT; causes: AF, myeloproliferative disease, sickle cell; conservative unless septic infarct/haemorrhage
Splenic Abscess	Rare but life-threatening (80% mortality in immunocompromised); hematogenous spread most common; unilocular → percutaneous drainage + antibiotics; multilocular → splenectomy

This is a shared conversation. Sign in to Orris to start your own chat.